All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
RxBio Inc. has been hard at work building the funding bridge it's counting on to take its lead candidate, RX100, down the home stretch toward approval.
